Arginase as a potential biomarker of disease progression: a molecular imaging perspective

G S. Clemente, A van Waarde, I F. Antunes… - International Journal of …, 2020 - mdpi.com
Arginase is a widely known enzyme of the urea cycle that catalyzes the hydrolysis of L-
arginine to L-ornithine and urea. The action of arginase goes beyond the boundaries of …

Metalloenzyme Inhibitors against Zoonotic Infections: Focus on Leishmania and Schistosoma

S Rossi, V Tudino, G Carullo, S Butini… - ACS Infectious …, 2024 - ACS Publications
The term “zoonosis” denotes diseases transmissible among vertebrate animals and
humans. These diseases constitute a significant public health challenge, comprising 61% of …

Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced …

OA Hamed, NAE El-Sayed, WR Mahmoud… - Bioorganic …, 2024 - Elsevier
Abstract Cyclin-dependent kinase 2 (CDK2) is a vital protein for controlling cell cycle
progression that is critically associated with various malignancies and its inhibition could …

[HTML][HTML] Computer-aided drug design approaches applied to screen natural product's structural analogs targeting arginase in Leishmania spp

HL Barazorda-Ccahuana, LD Goyzueta-Mamani… - …, 2023 - ncbi.nlm.nih.gov
Introduction: Leishmaniasis is a disease with high mortality rates and approximately 1.5
million new cases each year. Despite the new approaches and advances to fight the …

Cinnamides Target Leishmania amazonensis Arginase Selectively

ER da Silva, JAASS Come, S Brogi, V Calderone… - Molecules, 2020 - mdpi.com
Caffeic acid and related natural compounds were previously described as Leishmania
amazonensis arginase (L-ARG) inhibitors, and against the whole parasite in vitro. In this …

Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors

PG Camargo, CR Dos Santos, M Girão Albuquerque… - Scientific Reports, 2024 - nature.com
Leishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting
millions of people, mainly in tropical countries, due to poor social conditions and low …

Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update

A Dorababu - Archiv der Pharmazie, 2022 - Wiley Online Library
Among the menacing diseases, cancer needs the most attention as millions of people are
affected by it worldwide. Genetic and environmental factors play a pivotal role in causing …

Phenotypic investigation of 4-nitrophenylacetyl-and 4-nitro-1H-imidazoyl-based compounds as antileishmanial agents

CC Santos, H Zhang, MM Batista, GM de Oliveira… - Parasitology, 2022 - cambridge.org
Cutaneous leishmaniasis (CL) is a spectrum of clinical manifestations characterized by
severe skin ulcerations that leads to social stigma. There are limited treatment options for …

Overview of the Biological Activities of Pyrimido [4, 5-d] pyrimidines

JS Cruz, AP de Aguiar - Mini Reviews in Medicinal Chemistry, 2021 - ingentaconnect.com
Over the years, the development of bioactive heterocycles has aroused the interest of the
scientific community, because in general, these heterocycles are strategic in maintaining life …

Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level

M González-Matos, ME Aguado, M Izquierdo… - Experimental …, 2024 - Elsevier
Leishmaniasis are neglected infectious diseases caused by kinetoplastid protozoan
parasites from the genus Leishmania. These sicknesses are present mainly in tropical …